Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1990;81:1606-1621

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goldstein, D. S.
Right arrow Articles by Kopin, I. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goldstein, D. S.
Right arrow Articles by Kopin, I. J.

Circulation, Vol 81, 1606-1621, Copyright © 1990 by American Heart Association


ARTICLES

Positron emission tomographic imaging of cardiac sympathetic innervation and function

DS Goldstein, PC Chang, G Eisenhofer, R Miletich, R Finn, J Bacher, KL Kirk, S Bacharach and IJ Kopin
Hypertension-Endocrine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892.

Sites of uptake, storage, and metabolism of [18F]fluorodopamine and excretion of [18F]fluorodopamine and its metabolites were visualized using positron emission tomographic (PET) scanning after intravenous injection of the tracer into anesthetized dogs. Radioactivity was concentrated in the renal pelvis, heart, liver, spleen, salivary glands, and gall bladder. Uptake of 18F by the heart resulted in striking delineation of the left ventricular myocardium. Pretreatment with desipramine markedly decreased cardiac positron emission, consistent with dependence of the heart on neuronal uptake (uptake-1) for removal of circulating catecholamines. In reserpinized animals, cardiac positron emission was absent within 30 minutes after injection of [18F]-6-fluorodopamine, demonstrating that the emission in untreated animals was from radioactive labeling of the sympathetic storage vesicles. Decreased positron emission from denervated salivary glands confirmed that the tracer was concentrated in sympathetic neurons. Radioactivity in the gall bladder and urinary system depicted the hepatic and renal excretion of the tracer and its metabolites. Administration of tyramine or nitroprusside increased and ganglionic blockade with trimethaphan decreased the rate of loss of myocardial radioactivity. The results show that PET scanning after administration of [18F]fluorodopamine can be used to visualize sites of sympathetic innervation, follow the metabolism and renal and hepatic excretion of catecholamines, and examine cardiac sympathetic function.


This article has been cited by other articles:


Home page
JNMHome page
M. Hadi, C. C. Chen, M. Whatley, K. Pacak, and J. A. Carrasquillo
Brown Fat Imaging with 18F-6-Fluorodopamine PET/CT, 18F-FDG PET/CT, and 123I-MIBG SPECT: A Study of Patients Being Evaluated for Pheochromocytoma
J. Nucl. Med., July 1, 2007; 48(7): 1077 - 1083.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
D. N. Tipre and D. S. Goldstein
Cardiac and Extracardiac Sympathetic Denervation in Parkinson's Disease with Orthostatic Hypotension and in Pure Autonomic Failure
J. Nucl. Med., November 1, 2005; 46(11): 1775 - 1781.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. S. Goldstein, S.-T. Li, C. Holmes, and K. Bankiewicz
Sympathetic Innervation in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Primate Model of Parkinson's Disease
J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 855 - 860.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. Gourgiotis, N. J. Sarlis, J. C. Reynolds, C. VanWaes, M. J. Merino, and K. Pacak
Localization of Medullary Thyroid Carcinoma Metastasis in a Multiple Endocrine Neoplasia Type 2A Patient by 6-[18F]-Fluorodopamine Positron Emission Tomography
J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 637 - 641.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S.-T. Li, C. J. Tack, L. Fananapazir, and D. S. Goldstein
Myocardial perfusion and sympathetic innervation in patients with hypertrophic cardiomyopathy
J. Am. Coll. Cardiol., June 1, 2000; 35(7): 1867 - 1873.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
D. S. Goldstein, C. Holmes, R. O. Cannon, G. Eisenhofer, and I. J. Kopin
Sympathetic Cardioneuropathy in Dysautonomias
N. Engl. J. Med., March 6, 1997; 336(10): 696 - 702.
[Abstract] [Full Text] [PDF]